Scholars Central

OpinionPublished 28 Feb 2025

Advancements and Challenges in Clinical Trials for Gynecologic Cancer

Authors: Sonam Dema

Department of Gynecologic Oncology, Jigme Dorji Wangchuck National Referral Hospital, Thimphu, Bhutan

Insights in Gynecologic Oncology

Volume 10 · Issue 1 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Gynecologic cancers, including ovarian, cervical, endometrial, vulvar, and vaginal malignancies, remain significant global health concerns despite advancements in early detection and treatment. Clinical trials play a crucial role in the development of innovative therapies, improving survival rates, and enhancing the quality of life for affected women. This article explores the various phases of clinical trials, the latest breakthroughs in targeted therapies and immunotherapy, and the challenges encountered in trial design, patient recruitment, and regulatory approvals. Furthermore, it highlights the importance of precision medicine and biomarker-driven trials in advancing personalized treatment strategies. By addressing these aspects, this review underscores the critical role of clinical research in shaping the future of gynecologic oncology.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInsights in Gynecologic Oncology
  • SubjectOncology & Cancer
  • SubjectReproductive Medicine & Gynaecology
  • BylineArticles whose byline prints “Sonam Dema”